Product Introduction:
Glizid MV Tablet combines three antidiabetic agents: Glimepiride, Metformin, and Vildagliptin. This combination helps in effective blood sugar control by stimulating insulin release, reducing glucose production in the liver, and enhancing incretin hormone activity.
Uses:
-
Type 2 Diabetes Mellitus
-
Blood sugar management
-
Adjunct to diet and exercise for diabetes control
Benefits:
-
Controls fasting and postprandial blood glucose
-
Reduces insulin resistance
-
Improves pancreatic insulin secretion
-
Lowers risk of diabetes-related complications
-
Convenient triple-action formulation
Composition:
-
Glimepiride (0.2 mg)
-
Metformin Hydrochloride (500 mg)
-
Vildagliptin (80 mg)
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Nausea
-
Vomiting
-
Diarrhea
-
Dizziness
-
Abdominal discomfort
Safety Advice:
-
Alcohol: Avoid or limit alcohol consumption.
-
Pregnancy/Breastfeeding: Use only if prescribed.
-
Driving: May cause dizziness or hypoglycemia; use caution.
-
Kidney/Liver Issues: Consult doctor before use.
-
Dosage: Take with meals to reduce gastrointestinal discomfort.
-
Monitoring: Regular blood sugar monitoring is essential.
